Novozymes has a total of 15360 patents globally, out of which 6556 have been granted. Of these 15360 patents, more than 40% patents are active. The United States of America is where Novozymes has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Europe seems to be the main focused R&D center, and also Denmark is the origin country of Novozymes.
Novozymes was founded in the year 2000. The Company researches, develops, produces, and sells enzymes for industrial use. Novozymes works within three main segments: the technical enzyme market, the food enzyme market, and the animal feed enzyme market. The Company serves customer worldwide.
Do read about some of the most popular patents of Novozymes which have been covered by us in this article and also you can find Novozymes patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Novozymes patent portfolio.
How many patents does the CEO of Novozymes have?
The CEO Ester Baiget has 3 patents.
How many patents does Novozymes have?
Novozymes has a total of 15360 patents globally. These patents belong to 3404 unique patent families. Out of 15360 patents, 6206 patents are active.
How Many Patents did Novozymes File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Novozymes Applications Filed||Novozymes Patents Granted|
How many Novozymes patents are Alive/Dead?
How Many Patents did Novozymes File in Different Countries?
Countries in which Novozymes Filed Patents
|United States Of America||2996|
|Hong Kong (S.A.R.)||29|
|Gulf Cooperation Council||1|
Where are Research Centers of Novozymes Patents Located?
10 Best Novozymes Patents
WO2011098531A1 is the most popular patent in the Novozymes portfolio. It has received 821 citations so far from companies like Danisco Us Inc, Procter & Gamble, and Basf.
Below is the list of 10 most cited patents of Novozymes:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Novozymes patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Novozymes invention. They couldn’t because Novozymes had protected those before them.
Examiners at the USPTO referred 473 Novozymes patents in 1932 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Novozymes patent portfolio are Danisco, Procter & Gamble and the United States Department Of Energy.
List of the Companies whose Patents were rejected citing Novozymes –
|Company||Number of Patent Applications that faced Rejection Citing Novozymes Patents||Number of Rejections (102 & 103)|
|Procter & Gamble||51||128|
|United States Department Of Energy||47||121|
|Dsm Ip Assets Bv||35||74|
|Ecolab Usa Inc||12||26|
|Chevron Usa Inc||7||17|
Count of 102 and 103 Type Rejections based on Novozymes Patents
Top Novozymes Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Novozymes US Patent Applications were Granted?
Novozymes (Excluding its subsidiaries) has filed 2375 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1394 have been granted leading to a grant rate of 64.69%.
Below are the key stats of Novozymes patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Novozymes?
|Law Firm||Total Applications||Success Rate|
|Novozymes North America Inc||2020||63.22%|
|Nixon & Vanderhye Pc||12||100.00%|
|Fidelman Wolffe & Waldron||11||81.82%|
|Hamilton Brook Smith & Reynolds||11||54.55%|
|Fidelman & Wolffe||9||88.89%|
|Knobbe Martens Olson & Bear||9||66.67%|
|Sughrue Mion Zinn Macpeak & Seas||9||100.00%|
|Joseph B Harris||7||0%|
What are Novozymes key innovation segments?
What Technologies are Covered by Novozymes?
The chart below distributes patents filed by Novozymes